Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502240770

Apexbio Technology LLC Phentolamine Mesylate 65-28-1 100mg
SDP

Catalog No. 502240770
Encompass_Preferred

Phentolamine Mesylate (CAS 65-28-1) is a non-selective alpha-adrenergic antagonist that blocks both alpha 1- and alpha 2-adrenoreceptors By preferentially inhibiting presynaptic alpha 2-adrenoreceptors phentolamine increases the release of neurotransmitters such as noradrenaline leading to enhanced functional biological modulation (FBM) while also exerting effects on postsynaptic alpha 1-adrenoreceptors This dual antagonism makes phentolamine a valuable tool for investigating adrenergic signaling pathways neurotransmitter regulation and vascular tone in various biomedical research settings

This item is not returnable. View return policy
Catalog No. 50-224-0770 Supplier Apexbio Technology LLC Supplier No. B1363100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Phentolamine Mesylate (CAS 65-28-1) is a non-selective alpha-adrenergic antagonist that blocks both alpha 1- and alpha 2-adrenoreceptors By preferentially inhibiting presynaptic alpha 2-adrenoreceptors phentolamine increases the release of neurotransmitters such as noradrenaline leading to enhanced functional biological modulation (FBM) while also exerting effects on postsynaptic alpha 1-adrenoreceptors This dual antagonism makes phentolamine a valuable tool for investigating adrenergic signaling pathways neurotransmitter regulation and vascular tone in various biomedical research settings

This item is not returnable. View return policy
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.